| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2013 | US20130178434 Method of treating otitis externa using macrocyclic lactone compound |
| 07/11/2013 | US20130178433 Method of treating hemorrhoids using macrocyclic lactone compound |
| 07/11/2013 | US20130178430 Compositions for Prevention or Treatment of Hepatitis C Virus Containing ginsenoside Rg3 as an Active Ingredient |
| 07/11/2013 | US20130178424 Therapy for complications of diabetes |
| 07/11/2013 | US20130178420 Novel glp-1 receptor modulators |
| 07/11/2013 | US20130178418 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 07/11/2013 | US20130178417 Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
| 07/11/2013 | US20130178125 Marine coatings |
| 07/11/2013 | US20130177660 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
| 07/11/2013 | US20130177655 Preventing or treating agent for glaucoma |
| 07/11/2013 | US20130177654 Xenon-based anesthetic gas composition usable during an endarterectomy involving the clamping of the carotid artery |
| 07/11/2013 | US20130177652 Pharmaceutical oral dosage forms comprising dabigatran etexilate and its pharmaceutically acceptable salts |
| 07/11/2013 | US20130177650 Pellet formulation for the treatment of the intestinal tract |
| 07/11/2013 | US20130177647 Methods for manipulating satiety |
| 07/11/2013 | US20130177646 Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance |
| 07/11/2013 | US20130177644 Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 07/11/2013 | US20130177643 Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form |
| 07/11/2013 | US20130177642 Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 07/11/2013 | US20130177641 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors |
| 07/11/2013 | US20130177640 Delivery of rna to different cell types |
| 07/11/2013 | US20130177639 Delivery of rna to trigger multiple immune pathways |
| 07/11/2013 | US20130177632 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 07/11/2013 | US20130177631 Method and medicament for inhibiting the expression of a given gene |
| 07/11/2013 | US20130177627 Growth inhibitory effects of nanoparticles containing triterpene glycosides or triterpenes |
| 07/11/2013 | US20130177624 Mirna expression in allergic disease |
| 07/11/2013 | US20130177621 Imidazole Derivatives Useful for Controlling Microbial Growth |
| 07/11/2013 | US20130177619 Vitamin powder composition and method of making |
| 07/11/2013 | US20130177614 Method of use of stabilized non-plant-derived growth factor in skin care |
| 07/11/2013 | US20130177613 Packaging assembly for pharmaceutical composition including pimobendan |
| 07/11/2013 | US20130177612 Prebiotic Formulations and Methods of Use |
| 07/11/2013 | US20130177609 Compositions and Methods for Increasing Bioavailability of Topical Ophthalmic Drugs |
| 07/11/2013 | US20130177607 Nanocell Drug Delivery System |
| 07/11/2013 | US20130177606 Transdermal therapeutic system with cholinesterase inhibitor |
| 07/11/2013 | US20130177604 Compositions and Methods of Treating Metabolic Disorders |
| 07/11/2013 | US20130177599 Methods and kits for extending contact lens use |
| 07/11/2013 | US20130177590 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/11/2013 | US20130177580 TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY |
| 07/11/2013 | US20130177576 Compositions And Methods For The Treatment Of Neurologic And Psychiatric Conditions |
| 07/11/2013 | US20130177556 Egfr aptamer inhibitor for use in therapy and diagnosis |
| 07/11/2013 | US20130177552 Methods and compositions for modulating ocular damage |
| 07/11/2013 | US20130177549 Treatment of Synucleinopathies |
| 07/11/2013 | US20130177543 Natural Means of Augmenting Endogenous Stem Cell Numbers |
| 07/11/2013 | US20130177531 Inhibitors of Serine Proteases |
| 07/11/2013 | US20130177530 Antiviral compounds |
| 07/11/2013 | US20130177529 Pyrazole Compounds |
| 07/11/2013 | US20130177525 Cancer therapy based on tumor associated antigens derived from cyclin d1 |
| 07/11/2013 | US20130177524 Methods for enhancing oxygenation of jeopardized tissue |
| 07/11/2013 | US20130177522 Non-irritating opthalmic povidone-iodine compositions |
| 07/11/2013 | US20130177513 Extract of aerial parts of maca rich in polyphenols and composition comprising same |
| 07/11/2013 | US20130177506 Bio-Available Chlorogenic Acid Preparations for Supplemental Human Consumption and Use |
| 07/11/2013 | US20130177498 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 07/11/2013 | DE102012200352A1 Substituierte, annellierte Imidazole und Pyrazole und ihre Verwendung Substituted fused imidazoles and pyrazoles and their use |
| 07/11/2013 | CA2861141A1 Oromucosal liquid estradiol compositions |
| 07/11/2013 | CA2860669A1 Compositions and methods for treating metabolic disorders |
| 07/11/2013 | CA2856677A1 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 07/11/2013 | CA2856673A1 Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| 07/10/2013 | EP2612919A1 Sulfated polysaccharide capable of binding to growth factor and use thereof |
| 07/10/2013 | EP2612917A1 Antisense nucleic acid |
| 07/10/2013 | EP2612914A1 Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient |
| 07/10/2013 | EP2612862A2 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/10/2013 | EP2612861A1 Fluorinated thiazoles for use in treating cancer |
| 07/10/2013 | EP2612860A1 Quinazoline derivatives substituted by aniline, preparation method and use thereof |
| 07/10/2013 | EP2612857A1 Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate |
| 07/10/2013 | EP2612854A1 Aminothiazolidine and aminotetrahydrothiazepine derivatives as BACE 1 inhibitors |
| 07/10/2013 | EP2612853A1 c-Met modulators and methods of use |
| 07/10/2013 | EP2612850A1 Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it |
| 07/10/2013 | EP2612848A1 Cyclic amide derivative |
| 07/10/2013 | EP2612703A2 Particulate materials |
| 07/10/2013 | EP2612677A1 Preparation comprising insulin, nicotinamide and an amino acid |
| 07/10/2013 | EP2612672A1 Bioeffective krill oil compositions |
| 07/10/2013 | EP2612671A1 A clinical preparation of scutellarin and the preparation method thereof |
| 07/10/2013 | EP2612670A2 Anesthetic association, anesthetic composition, and anesthetic medicament for veterinary use |
| 07/10/2013 | EP2612669A2 Use of the fetal reprogramming of a ppar agonist |
| 07/10/2013 | EP2612668A2 Pharmaceutical composition for the prevention or treatment of degenerative neurological brain disorders |
| 07/10/2013 | EP2612667A2 Anticaries dentifrice composition that includes anticaries propolis as an active principle |
| 07/10/2013 | EP2612666A2 Treatments using citrulline |
| 07/10/2013 | EP2612665A1 Topical pharmaceutical compositions comprising bexarotene and a corticosteroide |
| 07/10/2013 | EP2612664A1 Stabilized polyphenol solution and method for stabilizing polyphenol solution |
| 07/10/2013 | EP2612663A1 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 07/10/2013 | EP2612662A1 Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| 07/10/2013 | EP2612661A1 Delayed release formulation for reducing the frequency of urination and method of use thereof |
| 07/10/2013 | EP2612660A1 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 07/10/2013 | EP2612659A1 Panaxatriol saponins enteric pellet, capsule comprising same and method for preparing same |
| 07/10/2013 | EP2612658A1 Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide |
| 07/10/2013 | EP2612656A1 Process for producing drug block-copolymer composite and pharmaceutical product containing same |
| 07/10/2013 | EP2612646A1 Process for the production of alcoholic gels for skin and hand disinfection |
| 07/10/2013 | EP2612629A1 Compositions for transdermal oxybutynin therapy |
| 07/10/2013 | EP2612560A1 Glutamine enriched nutritional composition for preterm infants |
| 07/10/2013 | EP2612553A1 Compositions and Methods for Prophylaxis and Treatment of Addictions |
| 07/10/2013 | EP2611920A2 Vesicular stomatitis viruses |
| 07/10/2013 | EP2611919A2 Kinases as targets for anti-diabetic therapy |
| 07/10/2013 | EP2611918A1 Mirnas involved in the blood brain barrier function |
| 07/10/2013 | EP2611818A2 Phosphonate ester derivatives and methods of synthesis thereof |
| 07/10/2013 | EP2611812A1 Thienopyridine and thienopyrimidine compounds and methods of use thereof |
| 07/10/2013 | EP2611810A1 Substituted tetrahydropyrrolopyrazine derivatives |
| 07/10/2013 | EP2611809A1 Azolopyridine and azolopyrimidine compounds and methods of use thereof |
| 07/10/2013 | EP2611808A1 Pyrazolopyridinone derivatives as lpa receptor antagonists |
| 07/10/2013 | EP2611806A1 Deuterium-enriched heterocyclic compounds as kinase inhibitors |
| 07/10/2013 | EP2611805A1 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment |
| 07/10/2013 | EP2611804A1 Novel compounds and compositions for the inhibition of nampt |